Laurus Labs Limited Market Cap ($13.57 Billion)
Market Cap & Net Worth: Laurus Labs Limited (LAURUSLABS)
Laurus Labs Limited market cap. Laurus Labs Limited (NSE:LAURUSLABS) has a market capitalization of $13.57 Billion (Rs1.26 Trillion) as of November 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #1722 globally and #59 in its home market, demonstrating a 12.83% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Laurus Labs Limited's stock price Rs2323.00 by its total outstanding shares 540312218 (540.31 Million). Also see Laurus Labs Limited (LAURUSLABS) cash flow conversion for how efficiently the company converts equity into cash flow.
Laurus Labs Limited Market Cap History (2016–2026)
Laurus Labs Limited market cap history from 2016 to 2026. Data shows growth from $526.61 Million to $13.57 Billion (38.96% CAGR). Check LAURUSLABS share price today for real-time trading data and today's change.
Index Memberships
Laurus Labs Limited is a constituent of 8 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY PHARMA
CNXPHARMA
|
$103.48 Billion | 13.12% | #2 of 20 |
|
NIFTY SMALLCAP 100
NIFSMCP100
|
$205.91 Billion | 6.59% | #1 of 100 |
|
NIFTY 500
NIFTY500
|
$3.02 Trillion | 0.45% | #56 of 500 |
|
NIFTY HEALTHCARE
NIFTYHEALTHCARE
|
$119.73 Billion | 11.34% | #2 of 20 |
|
NIFTY MIDSMALLCAP 400
NIFTYMIDSML400
|
$1.09 Trillion | 1.25% | #8 of 400 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.10 Trillion | 0.44% | #55 of 750 |
|
NIFTY SMALLCAP 250
NISM250
|
$388.02 Billion | 3.50% | #1 of 250 |
|
NIFTY SMALLCAP 50
NISM50
|
$131.63 Billion | 10.31% | #1 of 50 |
Weight: Laurus Labs Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Laurus Labs Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Laurus Labs Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Laurus Labs Limited (LAURUSLABS) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.20x
Laurus Labs Limited's market cap is 0.20 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.53x
Laurus Labs Limited's market cap is 1.53 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $596.00 Million | $19.05 Billion | $1.90 Billion | 0.03x | 0.31x |
| 2018 | $418.04 Million | $20.56 Billion | $1.68 Billion | 0.02x | 0.25x |
| 2019 | $406.60 Million | $22.92 Billion | $937.64 Million | 0.02x | 0.43x |
| 2020 | $2.03 Billion | $28.32 Billion | $2.55 Billion | 0.07x | 0.80x |
| 2021 | $3.12 Billion | $48.14 Billion | $9.84 Billion | 0.06x | 0.32x |
| 2022 | $2.18 Billion | $49.36 Billion | $8.28 Billion | 0.04x | 0.26x |
| 2023 | $2.51 Billion | $60.41 Billion | $7.90 Billion | 0.04x | 0.32x |
| 2024 | $3.52 Billion | $50.41 Billion | $1.61 Billion | 0.07x | 2.19x |
| 2025 | $6.47 Billion | $55.54 Billion | $3.58 Billion | 0.12x | 1.81x |
| 2026 | $13.57 Billion | $68.13 Billion | $8.89 Billion | 0.20x | 1.53x |
Competitor Companies of LAURUSLABS by Market Capitalization
Companies near Laurus Labs Limited in the global market cap rankings as of November 4, 2026. Also see Laurus Labs Limited total assets for a full breakdown of the balance sheet.
Key companies related to Laurus Labs Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #534 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #580 globally with a market cap of $46.03 Billion USD ( CN¥314.55 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #509 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #534 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.90 |
| #580 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.03 Billion | CN¥49.31 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Laurus Labs Limited (2016–2026)
Market capitalization of Laurus Labs Limited from 2016 to today. Between 2016 and today, Laurus Labs Limited's market cap moved from $526.61 Million to $ 13.57 Billion, with a yearly change of 38.96%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs13.57 Billion | +109.66% |
| 2025 | Rs6.47 Billion | +83.84% |
| 2024 | Rs3.52 Billion | +40.34% |
| 2023 | Rs2.51 Billion | +15.19% |
| 2022 | Rs2.18 Billion | -30.10% |
| 2021 | Rs3.12 Billion | +53.28% |
| 2020 | Rs2.03 Billion | +400.06% |
| 2019 | Rs406.60 Million | -2.74% |
| 2018 | Rs418.04 Million | -29.86% |
| 2017 | Rs596.00 Million | +13.18% |
| 2016 | Rs526.61 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Laurus Labs Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.57 Billion USD |
| MoneyControl | $13.57 Billion USD |
| MarketWatch | $13.57 Billion USD |
| marketcap.company | $13.57 Billion USD |
| Reuters | $13.57 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Laurus Labs Limited
Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and solid oral drug products for intermediates for anti-retroviral (ARV), anti-diabetic, cardiovascular, anti-asthma, ophthalmology, oncology, and gastroenterology. It also develops and manufactures animal… Read more